Pacific Edge, PPO MultiPlan Sign Deal Covering Bladder Cancer Dx | GenomeWeb

NEW YORK (GenomeWeb) – Pacific Edge recently announced a contract with preferred provider organization MultiPlan covering Pacific Edge's Cxbladder test.

The deal provides coverage of the bladder cancer test to MultiPlan's members and includes Pacific Edge's participation in the MultiPlan, PHCS, and PHCS Savility Networks. About 900,000 providers participate in MultiPlan's networks and about 68 million patients have access to the networks, Pacific Edge said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.